Supernus Pharmaceuticals, Inc. (SUPN)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Supernus Pharmaceuticals, Inc. (SUPN) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $2.55B, a trailing price-to-earnings ratio of 19.6 and a free-cash-flow yield of 1.9%. Over the most recent reported fiscal year, revenue grew 8.6% and free cash flow per share fell 73.4%.

Market cap	$2.55B
Trailing P/E	19.6
FCF yield	1.9%
Revenue growth (YoY)	+8.6%
EPS growth (YoY)	+10.9%
FCF/share growth (YoY)	-73.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live SUPN data on Nama Insights →

Recent Congressional trades

Supernus Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Apr 7, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jan 12, 2026
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Nov 18, 2025
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Apr 7, 2025